Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...

We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...

Bankrupt genetics company 23andMeMEHCQ wants to reopen bidding on its assets after former Chief Executive Anne Wojcicki put together a $305 million offer, topping Regeneron ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

Regeneron Pharmaceuticals ... inking an R&D alliance with GSK in 2018 and then later building its own pipeline of experimental medicines.

TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported first-quarter profit of $808.7 million. The Tarrytown, New York-based company said it ...

George Yancopoulos, co-founder of biotech company Regeneron, has purchased almost all of the condominium units in a mixed-use Tribeca building, according to city records made public this week.

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...